Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $304.31 | $7.10 | 4,188.86% | 6,086.20x | 214.14x | 6.74x | 8.16x | 16.40x | $529.27M | 1.58% | $4.13B | 37.48 | $31.58B | 99.29 | ||
| CORT | CORCEPT THERAPEUTICS INC | $81.12 | $29.40 | 175.96% | 81.12x | 79.37x | 11.33x | 13.50x | 1.26x | $162.57M | 1.94% | $631.90M | 6.10 | $8.41B | 127.53 | ||
| NVO | NOVO NORDISK A S | $48.96 | $141.95 | -65.51% | 13.62x | 2.05x | 4.47x | 8.31x | 0.15x | $9.34B | 4.29% | $26.18B | 5.89 | $228.21B | 9.20 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $391.17 | $29.50 | 1,225.91% | 1,261.84x | 208.94x | 16.02x | 220.95x | 5.18x | $221.36M | 0.43% | $233.89M | 1.78 | $53.40B | 351.50 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.12 | $11.66 | -30.36% | 16.92x | 6.22x | 5.38x | 3.43x | 0.33x | -$23.64M | -5.21% | $133.17M | 2.38 | $465.41M | 6.93 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $41.37 | $14.84 | 178.86% | 84.43x | 41.46x | 5.17x | 5.86x | 1.26x | $101.73M | 3.29% | $535.38M | 7.17 | $2.97B | 55.44 | ||
| GMAB | GENMAB A | $31.35 | $108.38 | -71.07% | 13.38x | 1.74x | 5.65x | 3.50x | 0.12x | $1.19B | 5.93% | $5.75B | 8.96 | $18.51B | 9.25 | ||
| ARGX | ARGENX SE | $851.42 | $276.82 | 207.57% | 34.02x | 47.33x | 27,465.16x | 7.25x | 2.35x | $467.72M | 0.90% | $7.17B | 117.50 | $49.56B | 61.09 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $192.63 | $64.70 | 197.71% | 83.39x | 24.99x | 15.01x | 3.99x | 1.37x | $30.76M | 0.82% | $950.17M | 48.53 | $4.10B | 39.83 | ||
| VCEL | VERICEL CORP | $35.50 | $6.63 | 435.69% | 136.54x | 129.51x | 6.93x | 5.58x | 2.54x | $20.38M | 1.14% | $321.86M | 6.38 | $1.79B | 61.17 | ||
| TECH | BIO-TECHNE CORP | $57.44 | $16.34 | 251.60% | 114.88x | 28.41x | 7.34x | 4.55x | 1.57x | $224.06M | 2.51% | $1.97B | 12.65 | $9.20B | 41.65 | ||
| RPRX | ROYALTY PHARMA PLC | $38.38 | $42.26 | -9.19% | 21.81x | 7.98x | 7.05x | 2.30x | 0.44x | $2.11B | 12.74% | $9.62B | 22.28 | $30.16B | 28.88 | ||
| KRYS | KRYSTAL BIOTECH INC | $238.55 | $67.54 | 253.19% | 34.57x | 38.18x | 18.51x | 6.08x | 3.14x | $166.02M | 2.40% | $1.14B | 39.30 | $6.53B | 33.80 | ||
| VCYT | VERACYTE INC | $43.22 | $9.20 | 369.60% | 110.82x | 82.54x | 6.87x | 2.72x | 2.28x | $98.21M | 2.89% | $1.26B | 15.98 | $3.14B | 55.09 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.58 | $0.75 | 907.48% | 108.29x | 49.54x | 6.42x | 7.16x | 7.95x | $3.05M | 0.45% | $101.92M | 1.12 | $690.97M | 52.23 | ||
| CRMD | CORMEDIX INC | $11.44 | $13.22 | -13.44% | 5.04x | 4.57x | 4.05x | 2.41x | 26.21x | $74.42M | 8.57% | $374.13M | 4.93 | $1.00B | 8.92 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.85 | $7.73 | 105.14% | 27.33x | 20.89x | 7.86x | 5.71x | 1.32x | $119.87M | 5.74% | $365.77M | 2.78 | $2.09B | 20.24 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $51.77 | $41.78 | 23.93% | 19.03x | 17.50x | 3.21x | 1.64x | 0.73x | $832.13M | 8.37% | $6.06B | 31.54 | $9.29B | 12.03 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.81 | $1.30 | 39.35% | 25.86x | 71.54x | 2.32x | 2.75x | 0.74x | -$11.69M | -8.12% | $52.91M | 0.67 | $140.09M | 15.79 | ||
| HALO | HALOZYME THERAPEUTICS INC | $64.47 | $75.02 | -14.06% | 13.18x | 10.07x | 6.08x | 15.05x | 0.50x | $602.40M | 7.97% | $503.92M | 4.30 | $8.67B | 10.26 | ||
| EXEL | EXELIXIS INC | $41.60 | $29.13 | 42.82% | 16.91x | 16.09x | 4.88x | 5.16x | 1.02x | $779.77M | 6.98% | $2.16B | 8.05 | $10.95B | 11.81 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.83 | $36.76 | 5.62% | 12.02x | 11.92x | 2.71x | 2.68x | 0.78x | $296.89M | 13.29% | $835.12M | 14.51 | $1.76B | 6.52 | ||
| MNKD | MANNKIND CORP | $5.91 | $1.43 | 312.84% | 59.10x | 74.25x | 5.78x | -40.73x | 2.53x | $43.39M | 2.39% | -$44.55M | -0.15 | $2.05B | 27.97 | ||
| INCY | INCYTE CORP | $97.03 | $67.82 | 43.07% | 16.06x | 13.90x | 3.94x | 4.10x | 1.08x | $1.20B | 6.31% | $4.65B | 23.77 | $16.63B | 9.88 | ||
| INVA | INNOVIVA INC | $19.92 | $15.34 | 29.84% | 10.54x | 9.30x | 3.54x | 1.47x | 1.63x | $196.54M | 14.29% | $1.01B | 14.63 | $1.27B | 5.91 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $454.96 | $169.43 | 168.53% | 31.79x | 24.35x | 9.92x | 6.67x | 1.92x | $3.34B | 2.87% | $17.32B | 67.76 | $112.33B | 24.09 | ||
| ADMA | ADMA BIOLOGICS INC | $19.17 | $9.33 | 105.42% | 21.78x | 32.04x | 9.36x | 10.58x | 1.65x | $40.73M | 0.89% | $431.19M | 1.81 | $4.57B | 26.58 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.34 | $3.31 | 91.34% | 23.48x | 34.16x | 4.06x | 7.16x | 1.32x | $21.15M | 4.18% | $70.68M | 0.89 | $444.74M | 19.60 | ||
| UTHR | UNITED THERAPEUTICS CORP | $500.00 | $199.53 | 150.59% | 17.56x | 18.11x | 7.00x | 3.27x | 5.13x | $1.12B | 5.12% | $6.59B | 150.46 | $20.19B | 11.39 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.19 | $12.67 | 90.97% | 13.51x | 15.40x | 5.13x | 3.23x | 3.74x | $234.54M | 7.91% | $920.25M | 7.51 | $2.29B | 7.06 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $746.36 | $357.67 | 108.68% | 17.18x | 16.98x | 5.43x | 2.53x | 2.54x | $4.22B | 5.46% | $30.96B | 298.82 | $78.64B | 13.77 | ||
| MDXG | MIMEDX GROUP INC | $7.25 | $2.77 | 161.99% | 25.89x | 16.92x | 2.73x | 4.49x | 2.30x | $66.82M | 6.22% | $238.95M | 1.61 | $949.87M | 13.72 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.